Clinical impact of molecular genetic diagnosis, genetic counseling, and management of hereditary cancer: Part II: Hereditary nonpolyposis colorectal carcinoma as a model

Cancer

Volumn 86, Issue 11 SUPPL., 1999, Pages 2457-2463

  Lynch, Henry T ^a   Watson, Patrice ^a   Shaw, Trudy G ^a   Lynch, Jane F ^a   Harty, Anne E ^a   Franklin, Barbara A ^a   Kapler, Christine R ^a   Tinley, Susan T ^a   Liu, Bo ^b   Lerman, Caryn ^c  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

Author keywords

Cancer genetics; Colorectal carcinoma; Genetic counseling; Genetic testing; Hereditary cancer; Hereditary nonpolyposis colorectal carcinoma

Indexed keywords

CANCER SUSCEPTIBILITY; COLORECTAL CARCINOMA; CONFERENCE PAPER; FAMILIAL CANCER; GENE MUTATION; GENETIC COUNSELING; HUMAN; MOLECULAR GENETICS; PRIORITY JOURNAL;

EID: 17144439173     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0142(19991201)86:11+<2457::aid-cncr2>3.0.co;2-i     Document Type: Conference Paper

References (28)

1. Fearon EB, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
2. Aaltonen LA, Salovaara R, Kristo P, Canzian F, Hemminki A, Peltomaki P, et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 1998;338:1481-7.
3. Lynch HT, Smyrk TC. Identifying hereditary nonpolyposis colorectal cancer. N Engl J Med 1998;338:1537-8.
4. Smith CM, Wells SA, Gerhard DS. Mapping eight new polymorphisms in 11q13 in the vicinity of multiple endocrine neoplasia type 1: identification of a new distal recombinant. Hum Genet 1995;96:377-87.
5. Donis-Keller H, Dou S, Chi D, Carlson KM, Toshima K, Lairmore TC, et al. Mutations in the ret proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet 1993; 2:851-6.
6. Fearon ER. Human cancer syndromes: clues to the origin and nature of cancer. Science 1997;278:1043-50.
7. Fishel R, Lescoe MK, Rao MR, Copeland NG, Jenkins NA, Garber J, et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993;75:1027-38.
8. Nicolaides NC, Papadopoulos N, Liu B, Wei YF, Carter KC, Ruben SM, et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 1994;371:75-80.
9. Miyaki M, Konishi M, Tanaka K, Kikuchi-Yanoshita R, Muraoka M, Yasuno M, et al. Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nat Genet 1997;17:271-2.
10. Liu B, Farrington SM, Petersen GM, Hamilton SR, Parsons R, Papadopoulos N, et al. Genetic instability occurs in the majority of young patients with colorectal cancer. Nat Med 1995;1:348-52.
11. Liu B, Parsons R, Papadopoulos N, Nicolaides NC, Lynch HT, Watson P, et al. Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med 1996;2:169-74.
12. Hamilton SR. The molecular genetics of colorectal neoplasia. Gastroenterology 1993;105:3-7.
13. Sheng GG, Shao J, Sheng H, Hooton EB, Isakson PC, Morrow JD, et al. A selective cyclooxygenase 2 inhibitor suppresses the growth of H-ras-transformed rat intestinal epithelial cells. Gastroenterology 1997;113:1883-91.
14. Arber N, Han EK-H, Sgambato A, Piazza GA, Delohery TM, Begemann M, et al. A K-ras oncogene increases resistance to sulindac-induced apoptosis in rat enterocytes. Gastroenterology 1997;113:1892-900.
15. Elder DJE, Paraskeva C. NSAIDs to prevent colorectal cancer: a question of sensitivity. Gastroenterology 1997;113:1999-2003.
16. Kinzler KW, Vogelstein B. Lessons from hereditary colon cancer. Cell 1996;87:159-70.
17. Lynch HT, Smyrk TC, Watson P, Lanspa SJ, Lynch JF, Lynch PM, et al. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology 1993;104:1535-49.
18. Wijnen J, Vasen H, Khan PM, Menko FH, van der Klift H, van Leeuwen C, et al. Seven new mutations in hMSH2, an HNPCC gene, identified by denaturing gradient-gel electro-phoresis. Am J Hum Genet 1995;56:1060-6.
19. Mary J-L, Bishop T, Kolodner R, Lipford JR, Kane M, Weber W, et al. Mutational analysis of the hMSH2 gene reveals a three base pair deletion in a family predisposed to colorectal cancer development. Hum Mol Genet 1994;3:2067-9.
20. Nystrom-Lahti M, Kristo P, Nicolaides NC, Chang SY, Aaltonen LA, Moisio AL, et al. Founding mutations and Alu-mediated recombination in hereditary colon cancer. Nat Med 1995;1:1203-6.
21. Dunlop MG, Farrington SM, Carothers AD, Wyllie AH, Sharp L, Burn J, et al. Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet 1997;6: 105-10.
22. Lynch HT. Is there a role for prophylactic subtotal colectomy among hereditary nonpolyposis colorectal cancer germline mutation carriers? Dis Colon Rectum 1996;39:109-10.
23. Church JM. Prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer. Ann Med 1996;28:479-82.
24. Jass JR. Colorectal adenoma progression and genetic change: is there a link? Ann Med 1995;27:301-6.
25. Winawer SJ, Fletcher RH, Miller L, Godlee F, Stolar MH, Mulrow CD, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997;112:594-642.
26. Järvinen HJ, Mecklin J-P, Sistonen P. Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 1995;108:1405-11.
27. Vasen HFA, van Ballegooijen M, Buskens E, Kleibeuker JK, Taal BG, Griffioen G, et al. A cost-effectiveness analysis of colorectal screening of hereditary nonpolyposis colorectal carcinoma gene carriers. Cancer 1998;82:1632-7.
28. American Society of Clinical Oncology. Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility. J Clin Oncol 1996;14:1730-6.